Dysregulation of Mfn2 and Drp-1 proteins in heart failure1

Canadian Journal of Physiology and Pharmacology

Volumn 92, Issue 7, 2014, Pages 583-591

  Givvimani, Srikanth ^a   Pushpakumar, Sathnur ^a   Veeranki, Sudhakar ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cx 43; Drp 1; Fusion; Mfn2; Mitochondrial fission; Mmp 9; Pressure overload heart failure

Indexed keywords

3-(2,4-DICHLORO-5-METHOXYPHENYL)-2-SULFANYL-4(3H)-QUINAZOLINONE; CONNEXIN 43; DNM1L PROTEIN, HUMAN; GELATINASE B; GUANOSINE TRIPHOSPHATASE; MFN2 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MITOCHONDRIAL PROTEIN; QUINAZOLINONE DERIVATIVE;

ANIMAL; GENETICS; HEART FAILURE; HUMAN; METABOLISM; MITOCHONDRIAL DYNAMICS; PATHOPHYSIOLOGY;

ANIMALS; CONNEXIN 43; GTP PHOSPHOHYDROLASES; HEART FAILURE; HUMANS; MATRIX METALLOPROTEINASE 9; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; QUINAZOLINONES;

EID: 84903310020     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0060     Document Type: Review

References (135)

1. Ai, X., and Pogwizd, S.M. 2005. Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A. Circ. Res. 96(1): 54-63. doi:10.1161/01. RES.0000152325.07495.5a. PMID:15576650.
2. Alavi, M.V., and Fuhrmann, N. 2013. Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Mol. Neurodegener. 8: 32. doi:10.1186/1750-1326-8-32. PMID:24067127.
3. Alexander, C., Votruba, M., Pesch, U.E., Thiselton, D.L., Mayer, S., Moore, A., et al. 2000. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 26(2): 211-215. doi:10.1038/79944. PMID:11017080.
4. Ando, M., Katare, R.G., Kakinuma, Y., Zhang, D., Yamasaki, F., Muramoto, K., et al. 2005. Efferent vagal nerve stimulation protects heart against ischemiainduced arrhythmias by preserving connexin43 protein. Circulation, 112(2): 164-170. doi:10.1161/CIRCULATIONAHA.104.525493. PMID:15998674.
5. Bach, D., Naon, D., Pich, S., Soriano, F.X., Vega, N., Rieusset, J., et al. 2005. Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes, 54(9): 2685-2693. doi:10.2337/diabetes.54.9.2685. PMID:16123358.
6. Ballinger, S.W., Patterson, C., Knight-Lozano, C.A., Burow, D.L., Conklin, C.A., Hu, Z., et al. 2002. Mitochondrial integrity and function in atherogenesis. Circulation, 106(5): 544-549. doi:10.1161/01.CIR.0000023921.93743.89. PMID: 12147534.
7. Benova, T., Viczenczova, C., Radosinska, J., Bacova, B., Knezl, V., Dosenko, V., et al. 2013. Melatonin attenuates hypertension-related proarrhythmic myocardial maladaptation of connexin-43 and propensity of the heart to lethal arrhythmias. Can. J. Physiol. Pharmacol. 91(8): 633-639. doi:10.1139/cjpp-2012- 0393. PMID:23889002.
8. Bers, D.M. 2006. Altered cardiac myocyte Ca regulation in heart failure. Physiology (Bethesda), 21: 380-387. doi:10.1152/physiol.00019.2006. PMID:17119150.
9. Boengler, K., Konietzka, I., Buechert, A., Heinen, Y., Garcia-Dorado, D., Heusch, G., et al. 2007. Loss of ischemic preconditioning's cardioprotection in aged mouse hearts is associated with reduced gap junctional and mitochondrial levels of connexin 43. Am. J. Physiol. Heart Circ. Physiol. 292(4): H1764-H1769. PMID:17142336.
10. Boengler, K., Ruiz-Meana, M., Gent, S., Ungefug, E., Soetkamp, D., Miro-Casas, E., et al. 2012. Mitochondrial connexin 43 impacts on respiratory complex I activity and mitochondrial oxygen consumption. J. Cell. Mol. Med. 16(8): 1649-1655. doi:10.1111/j.1582-4934.2011.01516.x. PMID:22212640.
11. Breckenridge, D.G., Stojanovic, M., Marcellus, R.C., and Shore, G.C. 2003. Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol. J. Cell Biol. 160(7): 1115-1127. doi:10.1083/jcb.200212059. PMID: 12668660.
12. Brooks, C., Wei, Q., Cho, S.G., and Dong, Z. 2009. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J. Clin. Invest. 119(5): 1275-1285. doi:10.1172/JCI37829. PMID:19349686.
13. Buralli, S., Dini, F.L., Ballo, P., Conti, U., Fontanive, P., Duranti, E., et al. 2010. Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure. Am. J. Cardiol. 105(6): 853-856. doi:10.1016/j.amjcard.2009. 11.038. PMID:20211331.
14. Cartoni, R., Leger, B., Hock, M.B., Praz, M., Crettenand, A., Pich, S., et al. 2005. Mitofusins 1/2 and ERRalpha expression are increased in human skeletal muscle after physical exercise. J. Physiol. 567(1): 349-358. doi:10.1113/jphysiol.2005.092031. PMID:15961417.
15. Chen, H., Detmer, S.A., Ewald, A.J., Griffin, E.E., Fraser, S.E., and Chan, D.C. 2003. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J. Cell Biol. 160(2): 189-200. doi:10. 1083/jcb.200211046. PMID:12527753.
16. Chen, H., Chomyn, A., and Chan, D.C. 2005. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J. Biol. Chem. 280(28): 26185-26192. doi:10.1074/jbc.M503062200. PMID:15899901.
17. Chen, Y., Liu, Y., and Dorn, G.W., II. 2011. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ. Res. 109(12): 1327-1331. doi:10.1161/CIRCRESAHA.111.258723. PMID:22052916.
18. Cheng, G., Xu, G., Cai, H.W., Wang, H.H., and Bao, X.F. 2007. Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats. Acta Pharmacol. Sin. 28(4): 511-517. doi:10.1111/j.1745-7254.2007.00515.x. PMID:17376290.
19. Chung, S., Dzeja, P.P., Faustino, R.S., Perez-Terzic, C., Behfar, A., and Terzic, A. 2007. Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells. Nat. Clin. Pract. Cardiovasc. Med. 4(Suppl. 1): S60-S67. doi:10.1038/ncpcardio0766. PMID:17230217.
20. Colussi, C., Rosati, J., Straino, S., Spallotta, F., Berni, R., Stilli, D., et al. 2011. Nepsilon-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heart. Proc. Natl. Acad. Sci. U.S.A. 108(7): 2795-2800. doi:10.1073/pnas.1013124108. PMID:21282606.
21. Corral-Debrinski, M., Shoffner, J.M., Lott, M.T., and Wallace, D.C. 1992. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat. Res. 275(3-6): 169-180. doi:10.1016/0921-8734(92)90021-G. PMID:1383759.
22. Creemers, E.E., Cleutjens, J.P., Smits, J.F., and Daemen, M.J. 2001. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circ. Res. 89(3): 201-210. doi:10.1161/hh1501.094396. PMID: 11485970.
23. de Brito, O.M., and Scorrano, L. 2008. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature, 456(7222): 605-610. doi:10.1038/nature07534. PMID: 19052620.
24. De Vos, K.J., Allan, V.J., Grierson, A.J., and Sheetz, M.P. 2005. Mitochondrial function and actin regulate dynamin-related protein 1-dependent mitochondrial fission. Curr. Biol. 15(7): 678-683. doi:10.1016/j.cub.2005.02.064. PMID: 15823542.
25. Detmer, S.A., and Chan, D.C. 2007. Functions and dysfunctions of mitochondrial dynamics. Nat. Rev. Mol. Cell Biol. 8(11): 870-879. doi:10.1038/nrm2275. PMID: 17928812.
26. Diaz, F., and Moraes, C.T. 2008. Mitochondrial biogenesis and turnover. Cell Calcium, 44(1): 24-35. doi:10.1016/j.ceca.2007.12.004. PMID:18395251.
27. Dini, F.L., Buralli, S., Bajraktari, G., Elezi, S., Duranti, E., Metelli, M.R., et al. 2010. Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease. Biomed. Pharmacother. 64(5): 339-342. doi:10.1016/j.biopha.2009.09.008. PMID:19944559.
28. Disatnik, M.H., Ferreira, J.C., Campos, J.C., Gomes, K.S., Dourado, P.M., Qi, X., et al. 2013. Acute inhibition of excessive mitochondrial fission after myocardial infarction prevents long-term cardiac dysfunction. J. Am. Heart Assoc. 2(5): e000461. doi:10.1161/JAHA.113.000461. PMID:24103571.
29. Dorn, G.W., II, and Maack, C. 2013. SR and mitochondria: calcium cross-talk between kissing cousins. J. Mol. Cell. Cardiol. 55: 42-49. doi:10.1016/j.yjmcc. 2012.07.015. PMID:22902320.
30. Ducharme, A., Frantz, S., Aikawa, M., Rabkin, E., Lindsey, M., Rohde, L.E., et al. 2000. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J. Clin. Invest. 106(1): 55-62. doi:10.1172/JCI8768. PMID: 10880048.
31. Eldrup, N., Kragelund, C., Steffensen, R., and Nordestgaard, B.G. 2012. Prognosis by C-reactive protein and matrix metalloproteinase-9 levels in stable coronary heart disease during 15 years of follow-up. Nutr. Metab. Cardiovasc. Dis. 22(8): 677-683. doi:10.1016/j.numecd.2010.11.003. PMID:21194909.
32. Fang, L., Moore, X.L., Gao, X.M., Dart, A.M., Lim, Y.L., and Du, X.J. 2007. Downregulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo. Life Sci. 80(23): 2154-2160. doi:10.1016/j.lfs.2007.04.003. PMID:17499311.
33. Fernandez-Cobo, M., Gingalewski, C., Drujan, D., and De Maio, A. 1999. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine, 11(3): 216-224. doi:10.1006/cyto. 1998.0422. PMID:10209069.
34. Fialova, M., Dlugosova, K., Okruhlicova, L., Kristek, F., Manoach, M., and Tribulova, N. 2008. Adaptation of the heart to hypertension is associated with maladaptive gap junction connexin-43 remodeling. Physiol. Res. 57(1): 7-11. PMID:17223729.
35. Figueira, T.R., Barros, M.H., Camargo, A.A., Castilho, R.F., Ferreira, J.C., Kowaltowski, A.J., et al. 2013. Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid. Redox Signal. 18(16): 2029-2074. doi:10.1089/ars.2012.4729. PMID:23244576.
36. Frank, S., Gaume, B., Bergmann-Leitner, E.S., Leitner, W.W., Robert, E.G., Catez, F., et al. 2001. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell, 1(4): 515-525. doi:10.1016/S1534- 5807(01)00055-7. PMID:11703942.
37. Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko, G.V., Rudka, T., et al. 2006. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell, 126(1): 177-189. doi:10.1016/j.cell.2006. 06.025. PMID:16839885.
38. Friehs, I., Margossian, R.E., Moran, A.M., Cao-Danh, H., Moses, M.A., and del Nido, P.J. 2006. Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis. Basic Res. Cardiol. 101(3): 204-213. doi:10.1007/s00395- 005-0581-0. PMID:16369727.
39. Fromaget, C., el Aoumari, A., and Gros, D. 1992. Distribution pattern of connexin 43, a gap junctional protein, during the differentiation of mouse heart myocytes. Differentiation, 51(1): 9-20. doi:10.1111/j.1432-0436.1992.tb00675.x. PMID:1333424.
40. Gharanei, M., Hussain, A., Janneh, O., and Maddock, H.L. 2014. 15 Mitochondrial Division Inhibitor-1 protects against doxorubicin-induced cardiotoxicity. Heart, 100(Suppl. 1): A6. doi:10.1136/heartjnl-2013-305297.15.
41. Givvimani, S., Tyagi, N., Sen, U., Mishra, P.K., Qipshidze, N., Munjal, C., et al. 2010. MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure. Arch. Physiol. Biochem. 116(2): 63-72. doi:10.3109/13813451003652997. PMID:20230216.
42. Givvimani, S., Munjal, C., Gargoum, R., Sen, U., Tyagi, N., Vacek, J.C., et al. 2011. Hydrogen sulfide mitigates transition from compensatory hypertrophy to heart failure. J. Appl. Physiol. (1985), 110(4): 1093-1100. doi:10.1152/jappl physiol.01064.2010. PMID:21233344.
43. Givvimani, S., Munjal, C., Tyagi, N., Sen, U., Metreveli, N., and Tyagi, S.C. 2012. Mitochondrial division/mitophagy inhibitor (Mdivi) ameliorates pressure overload induced heart failure. PLoS One, 7(3): e32388. doi:10.1371/journal.pone.0032388. PMID:22479323.
44. Goubaeva, F., Mikami, M., Giardina, S., Ding, B., Abe, J., and Yang, J. 2007. Cardiac mitochondrial connexin 43 regulates apoptosis. Biochem. Biophys. Res. Commun. 352(1): 97-103. doi:10.1016/j.bbrc.2006.10.177. PMID:17107662.
45. Gudbjarnason, S., Mathes, P., and Ravens, K.G. 1970. Functional compartmentation of ATP and creatine phosphate in heart muscle. J. Mol. Cell, Cardiol. 1(3): 325-339. doi:10.1016/0022-2828(70)90009-X. PMID:5519941.
46. Hom, J., and Sheu, S.S. 2009. Morphological dynamics of mitochondria - a special emphasis on cardiac muscle cells. J. Mol. Cell. Cardiol. 46(6): 811-820. doi:10.1016/j.yjmcc.2009.02.023. PMID:19281816.
47. Hom, J.R., Gewandter, J.S., Michael, L., Sheu, S.S., and Yoon, Y. 2007. Thapsigargin induces biphasic fragmentation of mitochondria through calciummediated mitochondrial fission and apoptosis. J. Cell. Physiol. 212(2): 498-508. doi:10.1002/jcp.21051. PMID:17443673.
48. Hom, J., Yu, T., Yoon, Y., Porter, G., and Sheu, S.S. 2010. Regulation of mitochondrial fission by intracellular Ca2+ in rat ventricular myocytes. Biochim. Biophys. Acta, 1797(6-7): 913-921. doi:10.1016/j.bbabio.2010.03.018. PMID: 20347716.
49. Huang, Q.Y., Chen, Y.C., and Liu, S.P. 2012. Connexin 43, angiotensin II, endothelin 1, and type III collagen alterations in heart of rats having undergone fatal electrocution. Am. J. Forensic Med. Pathol. 33(3): 215-221. doi:10.1097/PAF.0b013e31823f04eb. PMID:22182986.
50. Imoto, M., Tachibana, I., and Urrutia, R. 1998. Identification and functional characterization of a novel human protein highly related to the yeast dynamin-like GTPase Vps1p. J. Cell Sci. 111(10): 1341-1349. PMID:9570752.
51. Jansen, J.A., van Veen, T.A., de Jong, S., van der Nagel, R., van Stuijvenberg, L., Driessen, H., et al. 2012. Reduced Cx43 expression triggers increased fibrosis due to enhanced fibroblast activity. Circ. Arrhythm. Electrophysiol. 5(2): 380-390. doi:10.1161/CIRCEP.111.966580. PMID:22368123.
52. Jong, G.P., Ma, T., Chou, P., Chang, M.H., Wu, C.H., Lis, P.C., et al. 2006. Serum MMP-9 activity as a diagnosing marker for the developing heart failure of post MI patients. Chin. J. Physiol. 49(2): 104-109. PMID:16830792.
53. Karbowski, M., and Youle, R.J. 2011. Regulating mitochondrial outer membrane proteins by ubiquitination and proteasomal degradation. Curr. Opin. Cell Biol. 23(4): 476-482. doi:10.1016/j.ceb.2011.05.007. PMID:21705204.
54. Kasahara, A., Cipolat, S., Chen, Y., Dorn, G.W., II, and Scorrano, L. 2013. Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. Science, 342(6159): 734-737. doi:10.1126/science.1241359. PMID:24091702.
55. Kostin, S. 2007. Zonula occludens-1 and connexin 43 expression in the failing human heart. J. Cell. Mol. Med. 11(4): 892-895. doi:10.1111/j.1582-4934.2007. 00063.x. PMID:17760848.
56. Labrousse, A.M., Zappaterra, M.D., Rube, D.A., and van der Bliek, A.M. 1999. C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane. Mol. Cell, 4(5): 815-826. doi:10.1016/S1097-2765(00)80391-3. PMID:10619028.
57. Lauer, D., Slavic, S., Sommerfeld, M., Thone-Reineke, C., Sharkovska, Y., Hallberg, A., et al. 2014. Angiotensin type 2 receptor stimulation ameliorates left ventricular fibrosis and dysfunction via regulation of tissue inhibitor of matrix metalloproteinase 1/matrix metalloproteinase 9 axis and transforming growth factor 1 in the rat heart. Hypertension, 63: e60-e67. doi:10.1161/ HYPERTENSIONAHA.113.02522. PMID:24379181.
58. Lin, H., Ogawa, K., Imanaga, I., and Tribulova, N. 2006. Alterations of connexin 43 in the diabetic rat heart. Adv. Cardiol. 42: 243-254. doi:10.1159/000092573. PMID:16646595.
59. Lu, G., Haider, H.K., Jiang, S., and Ashraf, M. 2009. Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43. Circulation, 119(19): 2587-2596. doi:10.1161/CIRCULATIONAHA. 108.827691. PMID:19414636.
60. Lu, G., Jiang, S., Ashraf, M., and Haider, K.H. 2012. Subcellular preconditioning of stem cells: mito-Cx43 gene targeting is cytoprotective via shift of mitochondrial Bak and Bcl-xL balance. Regen. Med. 7(3): 323-334. doi:10.2217/rme.12.13. PMID:22594326.
61. Lukyanenko, V., Chikando, A., and Lederer, W.J. 2009. Mitochondria in cardiomyocyte Ca2+ signaling. Int. J. Biochem. Cell Biol. 41(10): 1957-1971. doi:10. 1016/j.biocel.2009.03.011. PMID:19703657.
62. Maack, C., and O'Rourke, B. 2007. Excitation-contraction coupling and mitochondrial energetics. Basic Res. Cardiol. 102(5): 369-392. doi:10.1007/s00395-007-0666-z. PMID:17657400.
63. Mandal, S., Lindgren, A.G., Srivastava, A.S., Clark, A.T., and Banerjee, U. 2011. Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells. Stem Cells, 29(3): 486-495. doi:10.1002/stem. 590. PMID:21425411.
64. McCormack, J.G., and Denton, R.M. 1989. The role of Ca2+ ions in the regulation of intramitochondrial metabolism and energy production in rat heart. Mol. Cell. Biochem. 89(2): 121-125. doi:10.1007/BF00220763. PMID:2682206.
65. Meeusen, S., McCaffery, J.M., and Nunnari, J. 2004. Mitochondrial fusion intermediates revealed in vitro. Science, 305(5691): 1747-1752. doi:10.1126/science. 1100612. PMID:15297626.
66. Meeusen, S., DeVay, R., Block, J., Cassidy-Stone, A., Wayson, S., McCaffery, J.M., et al. 2006. Mitochondrial inner-membrane fusion and crista maintenance requires the dynamin-related GTPase Mgm1. Cell, 127(2): 383-395. doi:10.1016/j.cell.2006.09.021. PMID:17055438.
67. Merkwirth, C., Dargazanli, S., Tatsuta, T., Geimer, S., Lower, B., Wunderlich, F.T., et al. 2008. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev. 22(4): 476-488. doi:10.1101/gad.460708. PMID:18281461.
68. Milberg, P., Klocke, R., Frommeyer, G., Quang, T.H., Dieks, K., Stypmann, J., et al. 2011. G-CSF therapy reduces myocardial repolarization reserve in the presence of increased arteriogenesis, angiogenesis and connexin 43 expression in an experimental model of pacing-induced heart failure. Basic Res Cardiol. 106(6): 995-1008. doi:10.1007/s00395-011-0230-8. PMID:22072114.
69. Miro-Casas, E., Ruiz-Meana, M., Agullo, E., Stahlhofen, S., Rodriguez-Sinovas, A., Cabestrero, A., et al. 2009. Connexin43 in cardiomyocyte mitochondria contributes to mitochondrial potassium uptake. Cardiovasc. Res. 83(4): 747-756. doi:10.1093/cvr/cvp157. PMID:19460776.
70. Mishra, P.K., Chavali, V., Metreveli, N., and Tyagi, S.C. 2012. Ablation of MMP9 induces survival and differentiation of cardiac stem cells into cardiomyocytes in the heart of diabetics: a role of extracellular matrix. Can. J. Physiol. Pharmacol. 90(3): 353-360. doi:10.1139/y11-131. PMID:22394373.
71. Mizon-Gerard, F., de Groote, P., Lamblin, N., Hermant, X., Dallongeville, J., Amouyel, P., et al. 2004. Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction. Eur. Heart J. 25(8): 688-693. doi:10.1016/j.ehj.2004.01.015. PMID:15084374.
72. Moe, G.W., Laurent, G., Doumanovskaia, L., Konig, A., Hu, X., and Dorian, P. 2008. Matrix metalloproteinase inhibition attenuates atrial remodeling and vulnerability to atrial fibrillation in a canine model of heart failure. J. Card. Fail. 14(9): 768-776. doi:10.1016/j.cardfail.2008.07.229. PMID:18995182.
73. Morita, H., Khanal, S., Rastogi, S., Suzuki, G., Imai, M., Todor, A., et al. 2006. Selective matrix metalloproteinase inhibition attenuates progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure. Am. J. Physiol. Heart Circ. Physiol. 290(6): H2522-H2527. doi:10.1152/ajpheart.00932.2005. PMID:16428338.
74. Moshal, K.S., Tyagi, N., Moss, V., Henderson, B., Steed, M., Ovechkin, A., et al. 2005. Early induction of matrix metalloproteinase-9 transduces signaling in human heart end stage failure. J. Cell. Mol. Med. 9(3): 704-713. doi:10.1111/j.1582-4934.2005.tb00501.x. PMID:16202218.
75. Moshal, K.S., Singh, M., Sen, U., Rosenberger, D.S., Henderson, B., Tyagi, N., et al. 2006. Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am. J. Physiol. Heart Circ. Physiol. 291(6): H2825-H2835. doi:10.1152/ajpheart.00377.2006. PMID:16877562.
76. Moshal, K.S., Kumar, M., Tyagi, N., Mishra, P.K., Metreveli, N., Rodriguez, W.E., et al. 2009. Restoration of contractility in hyperhomocysteinemia by cardiacspecific deletion of NMDA-R1. Am. J. Physiol. Heart Circ. Physiol. 296(3): H887-H892. doi:10.1152/ajpheart.00750.2008. PMID:19181966.
77. Neef, S., and Maier, L.S. 2013. Novel aspects of excitation-contraction coupling in heart failure. Basic Res. Cardiol. 108(4): 360. doi:10.1007/s00395-013-0360-2. PMID:23740218.
78. Ngoh, G.A., Papanicolaou, K.N., and Walsh, K. 2012. Loss of mitofusin 2 promotes endoplasmic reticulum stress. J. Biol. Chem. 287(24): 20321-20332. doi:10. 1074/jbc.M112.359174. PMID:22511781.
79. Nguyen, D., Alavi, M.V., Kim, K.Y., Kang, T., Scott, R.T., Noh, Y.H., et al. 2011. A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics. Cell Death Dis. 2: e240. doi:10.1038/cddis.2011.117. PMID:22158479.
80. Olichon, A., Emorine, L.J., Descoins, E., Pelloquin, L., Brichese, L., Gas, N., et al. 2002. The human dynamin-related protein OPA1 is anchored to the mitochondrial inner membrane facing the inter-membrane space. FEBS Lett. 523(1-3): 171-176. doi:10.1016/S0014-5793(02)02985-X. PMID:12123827.
81. Ong, S.B., and Hausenloy, D.J. 2010. Mitochondrial morphology and cardiovascular disease. Cardiovasc. Res. 88(1): 16-29. doi:10.1093/cvr/cvq237. PMID: 20631158.
82. Ong, S.B., Subrayan, S., Lim, S.Y., Yellon, D.M., Davidson, S.M., and Hausenloy, D.J. 2010. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation, 121(18): 2012-2022. doi:10. 1161/CIRCULATIONAHA.109.906610. PMID:20421521.
83. Orrenius, S., Gogvadze, V., and Zhivotovsky, B. 2007. Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol. 47: 143-183. doi:10.1146/annurev.pharmtox.47.120505.105122. PMID:17029566.
84. Ovechkin, A.V., Tyagi, N., Rodriguez, W.E., Hayden, M.R., Moshal, K.S., and Tyagi, S.C. 2005. Role of matrix metalloproteinase-9 in endothelial apoptosis in chronic heart failure in mice. J. Appl. Physiol. (1985), 99(6): 2398-2405. doi:10.1152/japplphysiol.00442.2005. PMID:16081621.
85. Palade, G.E. 1953. An electron microscope study of the mitochondrial structure. J. Histochem. Cytochem. 1(4): 188-211. doi:10.1177/1.4.188. PMID:13069686.
86. Papanicolaou, K.N., Khairallah, R.J., Ngoh, G.A., Chikando, A., Luptak, I., O'Shea, K.M., et al. 2011. Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes. Mol. Cell. Biol. 31(6): 1309-1328. doi:10.1128/MCB.00911-10. PMID:21245373.
87. Papanicolaou, K.N., Ngoh, G.A., Dabkowski, E.R., O'Connell, K.A., Ribeiro, R.F., Jr., Stanley, W.C., et al. 2012. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROS-induced mitochondrial dysfunction and cell death. Am. J. Physiol. Heart Circ. Physiol. 302(1): H167-H179. doi:10.1152/ajpheart.00833.2011. PMID:22037195.
88. Peterson, J.T., Hallak, H., Johnson, L., Li, H., O'Brien, P.M., Sliskovic, D.R., et al. 2001. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation, 103(18): 2303-2309. doi:10.1161/01.CIR.103.18.2303. PMID:11342481.
89. Piquereau, J., Caffin, F., Novotova, M., Prola, A., Garnier, A., Mateo, P., et al. 2012. Down-regulation of OPA1 alters mouse mitochondrial morphology, PTP function, and cardiac adaptation to pressure overload. Cardiovasc. Res. 94(3): 408-417. doi:10.1093/cvr/cvs117. PMID:22406748.
90. Piquereau, J., Caffin, F., Novotova, M., Lemaire, C., Veksler, V., Garnier, A., et al. 2013. Mitochondrial dynamics in the adult cardiomyocytes: which roles for a highly specialized cell? Front. Physiol. 4: 102. doi:10.3389/fphys.2013.00102. PMID:23675354.
91. Puddu, P., Puddu, G.M., Galletti, L., Cravero, E., and Muscari, A. 2005. Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis. Cardiology, 103(3): 137-141. doi:10.1159/000083440. PMID:15665536.
92. Ruiz-Meana, M., Rodriguez-Sinovas, A., Cabestrero, A., Boengler, K., Heusch, G., and Garcia-Dorado, D. 2008. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury. Cardiovasc. Res. 77(2): 325-333. doi:10.1093/cvr/cvm062. PMID:18006437.
93. Ruiz-Meana, M., Nunez, E., Miro-Casas, E., Martinez-Acedo, P., Barba, I., Rodriguez-Sinovas, A., et al. 2014. Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol. J. Mol. Cell. Cardiol. 68: 79-88. doi:10.1016/j.yjmcc.2014.01.001. PMID:24434643.
94. Santel, A., and Fuller, M.T. 2001. Control of mitochondrial morphology by a human mitofusin. J. Cell Sci. 114(5): 867-874. PMID:11181170.
95. Saotome, M., Safiulina, D., Szabadkai, G., Das, S., Fransson, A., Aspenstrom, P., et al. 2008. Bidirectional Ca2+-dependent control of mitochondrial dynamics by the Miro GTPase. Proc. Natl. Acad. Sci. U.S.A. 105(52): 20728-20733. doi:10.1073/pnas.0808953105. PMID:19098100.
96. Sharp, W.W., Fang, Y.H., Han, M., Zhang, H.J., Hong, Z., Banathy, A., et al. 2014. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. FASEB J. 28(1): 316-326. doi:10.1096/fj.12-226225. PMID:24076965.
97. Sheu, J.J., Sun, C.K., Chang, L.T., Fang, H.Y., Chung, S.Y., Chua, S., et al. 2010. Shock wave-pretreated bone marrow cells further improve left ventricular function after myocardial infarction in rabbits. Ann. Vasc. Surg. 24(6): 809-821. doi:10.1016/j.avsg.2010.03.027. PMID:20638620.
98. Shevchenko, A.V., Golovanova, O.V., Konenkov, V.I., Tolkacheva, O.M., Maksimov, V.N., Voevoda, M.I., et al. 2010. [Analysis of the gene polymorphism of matrix metalloproteinase-2 and -9 in patients with coronary heart disease]. Ter. Arkh. 82(1): 31-34. PMID:20364697. [Article in Russian].
99. Smirnova, E., Shurland, D.L., Ryazantsev, S.N., and van der Bliek, A.M. 1998. A human dynamin-related protein controls the distribution of mitochondria. J. Cell Biol. 143(2): 351-358. doi:10.1083/jcb.143.2.351. PMID:9786947.
100. Soeki, T., Niki, T., Uematsu, E., Bando, S., Matsuura, T., Kusunose, K., et al. 2013. Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 protein. Heart Vessels, 28(6): 795-801. doi:10.1007/s00380-013-0333-2. PMID:23494606.
101. Soini, Y., Satta, J., Maatta, M., and Autio-Harmainen, H. 2001. Expression of MMP2, MMP9, MT1-MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart. J. Pathol. 194(2): 225-231. doi:10.1002/path.850. PMID:11400152.
102. Song, G., Hennessy, M., Zhao, Y.L., Li, Q., Han, W.D., Qi, Y., et al. 2006. Adrenoceptor blockade alters plasma gelatinase activity in patients with heart failure and MMP-9 promoter activity in a human cell line (ECV304). Pharmacol. Res. 54(1): 57-64. doi:10.1016/j.phrs.2006.02.006. PMID:16574429.
103. Song, Y.H., Cai, H., Gu, N., Qian, C.F., Cao, S.P., and Zhao, Z.M. 2011. Icariin attenuates cardiac remodelling through down-regulating myocardial apo- ptosis and matrix metalloproteinase activity in rats with congestive heart failure. J. Pharm. Pharmacol. 63(4): 541-549. doi:10.1111/j.2042-7158.2010.01241.x. PMID:21401606.
104. Song, Z., Chen, H., Fiket, M., Alexander, C., and Chan, D.C. 2007. OPA1 processing controls mitochondrial fusion and is regulated bymRNAsplicing, membrane potential, and Yme1L. J. Cell Biol. 178(5): 749-755. doi:10.1083/jcb.200704110. PMID:17709429.
105. Srisakuldee, W., Nickel, B.E., Fandrich, R.R., Jiang, Z.S., and Kardami, E. 2006. Administration of FGF-2 to the heart stimulates connexin-43 phosphorylation at protein kinase C target sites. Cell Commun. Adhes. 13(1-2): 13-19. doi:10.1080/ 15419060600631326. PMID:16613776.
106. Suen, D.F., Norris, K.L., and Youle, R.J. 2008. Mitochondrial dynamics and apoptosis. Genes Dev. 22(12): 1577-1590. doi:10.1101/gad.1658508. PMID:18559474.
107. Sun, C.K., Chang, L.T., Sheu, J.J., Chiang, C.H., Lee, F.Y., Wu, C.J., et al. 2009. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit. Care Med. 37(4): 1197-1205. doi:10.1097/CCM.0b013e31819c0667. PMID:19242323.
108. Sundstrom, J., Evans, J.C., Benjamin, E.J., Levy, D., Larson, M.G., Sawyer, D.B., et al. 2004. Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study. Circulation, 109(23): 2850-2856. doi:10.1161/01.CIR.0000129318.79570.84. PMID:15173025.
109. Suzuki, K., Brand, N.J., Allen, S., Khan, M.A., Farrell, A.O., Murtuza, B., et al. 2001. Overexpression of connexin 43 in skeletal myoblasts: Relevance to cell transplantation to the heart. J. Thorac. Cardiovasc. Surg. 122(4): 759-766. doi:10.1067/mtc.2001.116210. PMID:11581610.
110. Szabadkai, G., Simoni, A.M., Bianchi, K., De Stefani, D., Leo, S., Wieckowski, M.R., et al. 2006. Mitochondrial dynamics and Ca2+ signaling. Biochim. Biophys. Acta, 1763(5-6): 442-449. doi:10.1016/j.bbamcr.2006.04.002. PMID:16750865.
111. Szulik, M., Stabryla-Deska, J., Boidol, J., Lenarczyk, R., Kalarus, Z., and Kukulski, T. 2011. Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy. Kardiol. Pol. 69(10): 1043-1051. PMID:22006606.
112. Taguchi, N., Ishihara, N., Jofuku, A., Oka, T., and Mihara, K. 2007. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J. Biol. Chem. 282(15): 11521-11529. doi:10.1074/jbc.M607279200. PMID:17301055.
113. Tribulova, N., Shneyvays, V., Mamedova, L.K., Moshel, S., Zinman, T., Shainberg, A., et al. 2004. Enhanced connexin-43 and alpha-sarcomeric actin expression in cultured heart myocytes exposed to triiodo-L-thyronine. J. Mol. Histol. 35(5): 463-470. PMID:15571324.
114. Tyagi, N., Vacek, J.C., Givvimani, S., Sen, U., and Tyagi, S.C. 2010. Cardiac specific deletion of N-methyl-D-aspartate receptor 1 ameliorates mtMMP-9 mediated autophagy/mitophagy in hyperhomocysteinemia. J. Recept. Signal Transduct. Res. 30(2): 78-87. doi:10.3109/10799891003614808. PMID:20170426.
115. Tyagi, S.C., Kumar, S.G., Alla, S.R., Reddy, H.K., Voelker, D.J., and Janicki, J.S. 1996a. Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells. J. Cell. Physiol. 167(1): 137-147. doi:10. 1002/(SICI)1097-4652(199604)167:1<137::AID-JCP16>3.0.CO;2-8. PMID:8698831.
116. Tyagi, S.C., Kumar, S.G., Haas, S.J., Reddy, H.K., Voelker, D.J., Hayden, M.R., et al. 1996b. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy J. Mol. Cell. Cardiol. 28(7): 1415-1428. doi:10.1006/jmcc.1996.0132. PMID:8841929.
117. Vacek, T.P., Metreveli, N., Tyagi, N., Vacek, J.C., Pagni, S., and Tyagi, S.C. 2011. Electrical stimulation of cardiomyocytes activates mitochondrial matrix metalloproteinase causing electrical remodeling. Biochem. Biophys. Res. Commun. 404(3): 762-766. doi:10.1016/j.bbrc.2010.12.039. PMID:21167815.
118. Varadi, A., Johnson-Cadwell, L.I., Cirulli, V., Yoon, Y., Allan, V.J., and Rutter, G.A. 2004. Cytoplasmic dynein regulates the subcellular distribution of mitochondria by controlling the recruitment of the fission factor dynamin-related protein-1. J. Cell Sci. 117(19): 4389-4400. doi:10.1242/jcs.01299. PMID:15304525.
119. Verheule, S., van Kempen, M.J., te Welscher, P.H., Kwak, B.R., and Jongsma, H.J. 1997. Characterization of gap junction channels in adult rabbit atrial and ventricular myocardium. Circ. Res. 80(5): 673-681. doi:10.1161/01.RES.80.5. 673. PMID:9130448.
120. Vorovich, E.E., Chuai, S., Li, M., Averna, J., Marwin, V., Wolfe, D., et al. 2008. Comparison of matrix metalloproteinase 9 and brain natriuretic peptide as clinical biomarkers in chronic heart failure. Am. Heart J. 155(6): 992-997. doi:10.1016/j.ahj.2008.01.007. PMID:18513509.
121. Wagner, D.R., Delagardelle, C., Ernens, I., Rouy, D., Vaillant, M., and Beissel, J. 2006. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J. Card. Fail. 12(1): 66-72. doi:10.1016/j.cardfail.2005.08.002. PMID:16500583.
122. Wang, J.X., Jiao, J.Q., Li, Q., Long, B., Wang, K., Liu, J.P., et al. 2011. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynaminrelated protein-1. Nat. Med. 17(1): 71-78. doi:10.1038/nm.2282. PMID:21186368.
123. Wang, X., and Schwarz, T.L. 2009. The mechanism of Ca2+-dependent regulation of kinesin-mediated mitochondrial motility. Cell, 136(1): 163-174. doi:10.1016/j.cell.2008.11.046. PMID:19135897.
124. Welsh, P., Whincup, P.H., Papacosta, O., Wannamethee, S.G., Lennon, L., Thomson, A., et al. 2008. Serum matrix metalloproteinase-9 and coronary heart disease: a prospective study in middle-aged men. QJM, 101(10): 785-791. doi:10.1093/qjmed/hcn088. PMID:18676684.
125. White, K.E., Davies, V.J., Hogan, V.E., Piechota, M.J., Nichols, P.P., Turnbull, D.M., et al. 2009. OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy. Invest. Ophthalmol. Vis. Sci. 50(6): 2567-2571. doi:10.1167/iovs.08-2913. PMID:19234344.
126. Wilson, E.M., Gunasinghe, H.R., Coker, M.L., Sprunger, P., Lee-Jackson, D., Bozkurt, B., et al. 2002. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J. Card. Fail. 8(6): 390-398. doi:10.1054/jcaf. 2002.129659. PMID:12528092.
127. Yan, A.T., Yan, R.T., Spinale, F.G., Afzal, R., Gunasinghe, H.R., Arnold, M., et al. 2006. Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure. J. Card. Fail. 12(7): 514-519. doi:10.1016/j.cardfail.2006.05.012. PMID:16952784.
128. Yang, D.C., Ma, S.T., Tan, Y., Chen, Y.H., Li, D., Tang, B., et al. 2010. Imbalance of matrix metalloproteinases/tissue inhibitor of metalloproteinase-1 and loss of fibronectin expression in patients with congestive heart failure. Cardiology, 116(2): 133-141. doi:10.1159/000317245. PMID:20606426.
129. Yoon, Y., Krueger, E.W., Oswald, B.J., and McNiven, M.A. 2003. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol. Cell. Biol. 23(15): 5409-5420. doi:10.1128/MCB.23.15.5409-5420.2003. PMID:12861026.
130. Yu, T., Fox, R.J., Burwell, L.S., and Yoon, Y. 2005. Regulation of mitochondrial fission and apoptosis by the mitochondrial outer membrane protein hFis1. J. Cell Sci. 118(18): 4141-4151. doi:10.1242/jcs.02537. PMID:16118244.
131. Yu, T., Sheu, S.S., Robotham, J.L., and Yoon, Y. 2008. Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species. Cardiovasc. Res. 79(2): 341-351. doi:10.1093/cvr/cvn104. PMID:18440987.
132. Yu, H., Guo, Y., Mi, L., Wang, X., Li, L., and Gao, W. 2011. Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy. J. Cardiovasc. Pharmacol. Ther. 16(2): 205-211. doi:10.1177/1074248410385683. PMID:21106870.
133. Zepeda, R., Kuzmicic, J., Parra, V., Troncoso, R., Pennanen, C., Riquelme, J.A., et al. 2014. Drp1 loss-of-function reduces cardiomyocyte oxygen-dependence protecting the heart from ischemia-reperfusion injury. J. Cardiovasc. Pharmacol. In press. doi:10.1097/FJC.0000000000000071. PMID:24477044.
134. Zhang, Y., Kanter, E.M., Laing, J.G., Aprhys, C., Johns, D.C., Kardami, E., et al. 2008. Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblasts. Cell Commun. Adhes. 15(3): 289-303. doi:10.1080/15419060802198736. PMID:18923946.
135. Zhao, Y., Zhou, X., Liao, X., and Yang, Z. 2009. [Expression and significance of matrix metalloproteinase-1,9, tissue inhibitor of metalloproteinase-4 and extracellular matrix metalloproteinase inducer in the myocardium of congestive heart failure in patients with rheumatic heart diseases]. Zhong Nan D Xue Xue Bao Yi Xue Ban, 34(8): 790-795. PMID:19734590. [Article in Chinese].